- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CAD falls within cost-effectiveness range
Combining computer-aided detection with screening mammography increases marginal costs per year of life saved by 19%. This is well within the cost-effectiveness range of other medical procedures, according to a study presented Monday.
Combining computer-aided detection with screening mammography increases marginal costs per year of life saved by 19%. This is well within the cost-effectiveness range of other medical procedures, according to a study presented Monday.
An estimated 25% to 30% of all screening mammography exams performed in the U.S. are interpreted with the help of CAD, but to date no study has evaluated the cost-effectiveness its use, said Dr. Karen K. Lindfors, chief of breast imaging at the University of California, Davis.
Using a computer model based on published data, Lindfors and colleagues evaluated the impact of CAD costs by comparing three hypothetical groups of women aged 40 to 79: one undergoing screening mammography with CAD, one undergoing screening mammography without CAD, and a third undergoing observation without screening.
The computer model was based on cancer detection rates arising out of a prospective study of screening mammography and CAD published in 2001 by Dr. Timothy Freer.
In Freer's study, 12,860 screening mammograms were interpreted with the assistance of CAD over a one-year period. Cancer detection increased by 19.5%, and the proportion of early stage (0 and I) malignancies detected rose from 73% to 78% (Radiology 2001;220:781-786). Lindfors also based probability of outcomes on the Freer study.
Survival rates were modeled on five-year statistics generated by the American Cancer Society. Costs for screening mammography and CAD were based on 2003 average global Medicare reimbursements of $82.77 and $19.13, respectively.
Lindfors found that adding CAD to a mammography screening program results in a marginal cost per year of life saved (MCYLS) of $19,508.
The MCYLS to provide screening mammography without CAD compared with observation only is $16,023, she said.
"While the MCYLS that we found does fall within the accepted range for other medical procedures, a magnitude change in the cancer detection rate with CAD could dramatically increase its cost-effectiveness," Lindfors said.
Such data could be forthcoming, she said, citing research in press by Dr. Tommy E. Cupples of the South Carolina Comprehensive Breast Center that will report a MCYLS of $7933 when CAD is paired with screening mammography.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.
